155 related articles for article (PubMed ID: 9610942)
1. The abuse potential of zolpidem administered alone and with alcohol.
Wilkinson CJ
Pharmacol Biochem Behav; 1998 May; 60(1):193-202. PubMed ID: 9610942
[TBL] [Abstract][Full Text] [Related]
2. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Rush CR; Baker RW; Wright K
Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
[TBL] [Abstract][Full Text] [Related]
3. Modest abuse-related subjective effects of zolpidem in drug-naive volunteers.
Licata SC; Mashhoon Y; Maclean RR; Lukas SE
Behav Pharmacol; 2011 Apr; 22(2):160-6. PubMed ID: 21301324
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA
J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658
[TBL] [Abstract][Full Text] [Related]
5. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
Wilkinson CJ
J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the abuse liability of a dual orexin receptor antagonist: a crossover study of almorexant and zolpidem in recreational drug users.
Cruz HG; Hoever P; Chakraborty B; Schoedel K; Sellers EM; Dingemanse J
CNS Drugs; 2014 Apr; 28(4):361-72. PubMed ID: 24627301
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
[TBL] [Abstract][Full Text] [Related]
8. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
[TBL] [Abstract][Full Text] [Related]
9. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
Evans SM; Funderburk FR; Griffiths RR
J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
[TBL] [Abstract][Full Text] [Related]
10. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
Schoedel KA; Stockis A; Sellers EM
Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
[TBL] [Abstract][Full Text] [Related]
11. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management.
Liappas IA; Malitas PN; Dimopoulos NP; Gitsa OE; Liappas AI; Nikolaou ChK; Christodoulou GN
J Psychopharmacol; 2003 Mar; 17(1):131-5. PubMed ID: 12680751
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.
Hindmarch I; Legangneux E; Stanley N; Emegbo S; Dawson J
Br J Clin Pharmacol; 2006 Nov; 62(5):538-45. PubMed ID: 17061961
[TBL] [Abstract][Full Text] [Related]
13. Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure.
Sethi PK; Khandelwal DC
J Assoc Physicians India; 2005 Feb; 53():139-40. PubMed ID: 15847035
[TBL] [Abstract][Full Text] [Related]
14. Dependence on zolpidem in high dose.
Vartzopoulos D; Bozikas V; Phocas C; Karavatos A; Kaprinis G
Int Clin Psychopharmacol; 2000 May; 15(3):181-2. PubMed ID: 10870877
[TBL] [Abstract][Full Text] [Related]
15. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
[TBL] [Abstract][Full Text] [Related]
16. High dose zolpidem induced fetal neural tube defects.
Sharma A; Sayeed N; Khees CR; Akhtar S
Curr Drug Saf; 2011 Apr; 6(2):128-9. PubMed ID: 21385155
[TBL] [Abstract][Full Text] [Related]
17. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore.
Evans SM; Critchfield TS; Griffiths RR
Br J Addict; 1991 Dec; 86(12):1625-32. PubMed ID: 1686197
[TBL] [Abstract][Full Text] [Related]
18. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms.
Kao CL; Huang SC; Yang YJ; Tsai SJ
J Clin Psychiatry; 2004 Sep; 65(9):1287. PubMed ID: 15367062
[No Abstract] [Full Text] [Related]
19. [Zolpidem dependence and withdrawal seizure].
Pitchot W; Ansseau M
Rev Med Liege; 2009; 64(7-8):407-8. PubMed ID: 19777922
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
